drugset / Trial / NCT01037231
Phase 2/3 Oxabact Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering urinary oxalate levels in patients with primary hyperoxaluria.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxalobacter formigenes | Other / unclassified | 1e+07 unknown | — |